Clopidol (CAS 2971-90-6), C7H7Cl2NO, the formula weight is 192.04, the form is white or light yellow powder, slightly soluble in methanol and ethanol, insoluble in water.
Due to the COVID-19 pandemic, the global Clopidol market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Clopidol market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Clopidol landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Clopidol has a good effect on 9 species of Eimeria, especially for Eimeria tenella, and it is more suitable as a preventive or early treatment.
This report focuses on Clopidol volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Clopidol market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Clopidol Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
95% Purity Type
98% Purity Type
99% Purity Type
Others
Segment by Application
Anmial Medication
Human Medication
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Zhongya Pharm
Xinrunde Chemical
Da Hua Nong
Zhongsheng Pharm
Luxi Animal Phram
Da Hua Wei Ye
Hongwei Biology
Baiyunshan Baoshen
T-Pharm
Alco Pharm
Noa Hemis Pharm